Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer
Tjalling Bosse(Leiden University Medical Center), Vincent T.H.B.M. Smit(Leiden University Medical Center)
Cited by 209
Related Papers
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer
|International Journal of Gynecological Cancer|2015|757
Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas
|The Journal of Pathology|2019|401
Interpretation of somatic <i>POLE</i> mutations in endometrial carcinoma
|The Journal of Pathology|2019|389
ESMO–ESGO–ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up
|Radiotherapy and Oncology|2015|184